Tamsulosin and intraureteral aminophylline to improve ureteral access during primary retrograde intrarenal surgery
Official title: Comparative Efficacy of Tamsulosin, Intraureteral Aminophylline, and Their Combination in Facilitating Ureteral Access During Retrograde Intrarenal Surgery: A Multicenter Randomized Controlled Trial.
Run by Beni-Suef University · NCT07623876 · Data updated 2026-11-12
This trial tests whether taking tamsulosin before surgery, using aminophylline inside the ureter during the operation, or both, helps place the ureteral access sheath on the first try for adults with small unilateral kidney stones undergoing RIRS.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 322 (estimated) |
| Sponsor | Beni-Suef University Academic / other |
| Locations | 3 sites (Aswān, Aswan Governorate and 2 other locations) |
| Status | Recruiting |
| Started | May 6, 2026 |
| Main results expected | April 2027 |
| Study ends | May 2027 |
| Registry record updated | June 3, 2026 |
| Trial ID | NCT07623876 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older with a unilateral kidney stone 2 cm or smaller planned for primary RIRS requiring a 10/12 Fr ureteral access sheath.
✕Probably not a fit
Patients without ureteral resistance or spasm, or those not responsive to the studied pharmacologic strategies, may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, randomized study uses a 2x2 factorial design to compare preoperative tamsulosin, intraureteral aminophylline, both, or neither in adults with unilateral renal stones ≤2 cm planned for primary retrograde intrarenal surgery. Participants are randomized to one of four groups and receive either active drug or placebo capsules for 7 days before surgery, plus intraureteral aminophylline or placebo during the procedure. The primary outcome is successful first-attempt placement of the planned 10/12 Fr ureteral access sheath without the need for additional maneuvers or abandonment of the procedure. The trial aims to determine whether systemic and/or local pharmacologic strategies reduce ureteral resistance or spasm to facilitate access. This is a prospective, double-blind, placebo-controlled study conducted across multiple centers.
Why it matters
Potential benefit: If successful, the approach could simplify ureteral access during RIRS and reduce the need for additional procedures or delays.
How similar studies have gone: Previous research on alpha-blockers and smooth-muscle relaxants has shown potential to facilitate ureteral access in select cases, but this specific combination and design is being tested in a rigorous multicenter trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older. * Unilateral renal stone 2 cm or less in maximal diameter on preoperative imaging. * Scheduled for primary retrograde intrarenal surgery. * Ability to provide written informed consent. Exclusion Criteria: * Prior ureteral stenting on the study side. * Bilateral same-session retrograde intrarenal surgery. * Concomitant ureteral stone requiring primary semirigid ureteroscopy as the main procedure. * Known ureteral stricture or prior ureteral reconstructive surgery on the study side. * Active urinary tract infection or untreated positive urine culture. * Pregnancy. * Known allergy or contraindication to tamsulosin or aminophylline. * Significant cardiac arrhythmia, uncontrolled ischemic heart disease, seizure disorder, or hyperthyroidism. * Severe hepatic impairment. * Inability to comply with the 7-day preoperative medication protocol.
Where it's running
-
Department of Urology- Aswan University Hospitals
Aswān, Aswan Governorate, Egypt Recruiting -
Department of Urology- Beni-Suef University Hospitals
Banī Suwayf, Beni Suweif Governorate, Egypt Recruiting -
Urology Department- Sohag university Hospital
Sohag, Sohag Governorate, Egypt Recruiting
Study contacts
- Principal investigator: Hany F Badawy, MD — Faculty of Medicine, Beni-Suef University
- Study coordinator: Hany F Badawy, MD
- Email: Hanyfathy86@gmail.com@GMAIL.COM
- Phone: +201149525028
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Long-term safety of UAS-assisted vs sheathless RIRS in adults with kidney stones
This study tests whether using a ureteral access sheath during the initial RIRS affects long-term safety and outcomes in adults with kidney stones ≤20 mm.
-
Abdominal CT offered alongside lung screening for people who have smoked
We will test whether mentioning a possible extra abdominal CT in the lung screening invitation changes whether people aged 55–70 who have ever smoked attend their lung screening appointment.
-
Stone clearance with steerable ureteroscopic evacuation compared with other methods
This study tests whether the CVAC/SURE approach helps clear kidney stones more effectively than standard renal-stone interventions in patients needing ureteroscopy or PCNL.
-
Steerable Ureteroscopic Renal Evacuation (SURE) with CVAC vs standard ureteroscopy
This trial tests whether the SURE system with CVAC can improve outcomes compared with standard ureteroscopy with laser lithotripsy for kidney stones in adult patients.
-
Retrograde renal access with RetroPerc for percutaneous kidney stone removal
This study tries RetroPerc® to obtain kidney access during supine percutaneous nephrolithotomy in adults with 1.5–3 cm kidney stones.
-
Evaluating the Mediterranean diet in patients with kidney stones and bone diseases
This study is testing how well people with kidney stones and bone diseases stick to the Mediterranean diet to see if it can help manage their conditions better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.